Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;115(2):179-189.
doi: 10.14309/ajg.0000000000000437.

Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure

Thomas Chateau  1   2 , Roger Feakins  3 , Aude Marchal-Bressenot  4 , Fernando Magro  5   6   7 , Silvio Danese  8 , Laurent Peyrin-Biroulet  2
Affiliations

Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure

Thomas Chateau et al. Am J Gastroenterol. 2020 Feb.

Abstract

In recent years, the therapeutic goals in ulcerative colitis (UC) have become increasingly stringent. Histological features seem to be a reliable predictor of disease outcomes after therapy, and histological remission (HR) is the new frontier in the treatment of UC. Here, we first provide a historical perspective before reviewing indexes in the era of biologics; histology as a treatment goal in UC trials; the poor correlation between symptoms, endoscopy, and histology; and the impact of histology on disease outcomes. HR seems to be a promising end point for the treatment of UC because it is typically associated with better outcomes. Two new validated indexes are available to assess histology more accurately in trials, and they may also be applicable to clinical practice. Additional interventional trials are now necessary to establish definitions of HR and its potential for disease modification.

PubMed Disclaimer

References

    1. Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis, Lancet 2017;389:1756–70.
    1. Ng SC, Kamm MA. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009;15:935–50.
    1. Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol 2010;45:571–83.
    1. Targan SR, Karp LC. Inflammatory bowel disease diagnosis, evaluation and classification: State-of-the art approach. Curr Opin Gastroenterol 2007;23:390–4.
    1. Peyrin-Biroulet L, Ferrante M, Magro F, et al. Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5:477–83.

Publication types

MeSH terms

LinkOut - more resources